سعر ماجيكمايسين 2% كريم مهبلي 40 جرام 2026

Magicmycin 2% vaginal cream, 40 g (EGPI / Magic Pharma): clindamycin vaginal cream used intravaginally for bacterial vaginosis.

• Treatment of bacterial vaginosis (formerly Haemophilus, Gardnerella, non-specific, Corynebacterium or anaerobic vaginitis), after ruling out other pathogens such as Trichomonas, Chlamydia, N. gonorrhoeae, Candida and herpes simplex virus.Population: Non-pregnant women and pregnant women in the second and third trimestersDailyMed (U.S. National Library of Medicine)

• In non-pregnant women (3-day / 7-day courses): vaginal moniliasis 7.7% / 10.4%, vulvovaginitis 6.0% / 4.4%, vulvovaginal disorder 3.2% / 5.3%; also trichomonal vaginitis, vaginal discharge and pain, and systemic candidiasis less often.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• History of hypersensitivity to clindamycin, lincomycin or any component of the cream.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• History of regional enteritis, ulcerative colitis or antibiotic-associated colitis.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Pseudomembranous colitis (Clostridioides difficile) has been reported with clindamycin including topical/vaginal forms (about 5% of a vaginal dose is absorbed); consider this diagnosis in patients with diarrhoea.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• The cream contains mineral oil that may weaken latex or rubber condoms and diaphragms; their use within 72 hours after treatment is not recommended.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• May cause overgrowth of non-susceptible organisms, particularly Candida (vulvovaginal candidiasis); ingredients cause eye burning and irritation - rinse with water on accidental contact.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Neuromuscular blocking agentsSystemic clindamycin has neuromuscular blocking properties that may enhance their action; use with caution.DailyMed (U.S. National Library of Medicine)

• Clindamycin appears in breast milk after oral or IV doses; it is unknown whether it does after vaginal use. Not a reason to stop breastfeeding, but an alternative may be preferred; monitor the infant for diarrhoea, candidiasis or blood in the stool.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Clindamycin: Clindamycin phosphate is hydrolysed to clindamycin, which inhibits bacterial protein synthesis by binding to the 23S RNA of the 50S ribosomal subunit; it is mainly bacteriostatic.